Form 4 holding
Chief Medical Officer, Head of Research & Development
Nkarta, Inc.
- Security class
- Common Stock
- Shares / value
- 70,000
- Estimated value
- $134,169
- Report date
- 06 Jan 2026
- Price
- $1.92
- Ownership
- Direct
Shawn Marshall Rose - Chief Medical Officer, Head of Research & Development at Nkarta, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Chief Medical Officer, Head of Research & Development
- Issuer symbol
- NKTX on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
There are no Buy or Sell transactions made by Shawn Marshall Rose since 30 May 2025
Holdings reported by Shawn Marshall Rose for Nkarta, Inc.
Form 4 holding
Chief Medical Officer, Head of Research & Development
Nkarta, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 139,000
- Estimated value
- Report date
- 06 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Shawn Marshall Rose for Nkarta, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.